Day Lab research programme has led to significant research outputs of sustained quality, including °×С½ãÂÛ̳'s first biomaterial for tissue regeneration granted approval for clinical use by the Medicines and Healthcare Products Regulatory Agency and associated first-in-human phase I/II clinical trial. The technology is backed by a portfolio of patent families, industry collaborations and licencing agreements.
- The core areas of research are:
- Bowel & Bladder Health
- Cardiovascular Disease
- Cell Delivery
- Characterizing the Immune Response
- Combating Antimicrobial Resistance
- Drug Delivery
- Immunotherapy
- Magnetic Actuation
- TIPS Microspheres